180 related articles for article (PubMed ID: 36159816)
21. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
22. Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.
Li J; Yu H; Yao J; Jiang Z; Li Z; Cui X
Oxid Med Cell Longev; 2022; 2022():1747604. PubMed ID: 35864871
[TBL] [Abstract][Full Text] [Related]
23. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
24. RNA modification patterns based on major RNA modifications define tumor microenvironment characteristics in glioblastoma.
Li G; Zhu Y; Gu J; Zhang T; Wang F; Huang K; Gu C; Xu K; Zhan R; Shen J
Sci Rep; 2022 Jun; 12(1):10278. PubMed ID: 35717510
[TBL] [Abstract][Full Text] [Related]
25. SnoRNA and lncSNHG: Advances of nucleolar small RNA host gene transcripts in anti-tumor immunity.
Xiao H; Feng X; Liu M; Gong H; Zhou X
Front Immunol; 2023; 14():1143980. PubMed ID: 37006268
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy.
Zhao R; Pan Z; Li B; Zhao S; Zhang S; Qi Y; Qiu J; Gao Z; Fan Y; Guo Q; Qiu W; Wang S; Wang Q; Zhang P; Guo X; Deng L; Xue H; Li G
Front Immunol; 2022; 13():820673. PubMed ID: 35309323
[TBL] [Abstract][Full Text] [Related]
27. Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targets.
Yadav G; Kulshreshtha R
J Cell Physiol; 2022 Jan; 237(1):401-420. PubMed ID: 34533835
[TBL] [Abstract][Full Text] [Related]
28. Association between small nucleolar RNA host gene expression and survival outcome of colorectal cancer patients: A meta-analysis based on PRISMA and bioinformatics analysis.
Luo P; Du J; Li Y; Ma J; Shi W
Front Oncol; 2023; 13():1094131. PubMed ID: 36895488
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs involved in the EGFR pathway in glioblastoma.
Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
31. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
32. Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma.
Zhang H; Zhang N; Wu W; Zhou R; Li S; Wang Z; Dai Z; Zhang L; Liu Z; Zhang J; Luo P; Liu Z; Cheng Q
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36136350
[TBL] [Abstract][Full Text] [Related]
33. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
[TBL] [Abstract][Full Text] [Related]
34. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
[TBL] [Abstract][Full Text] [Related]
35. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
36. Long Non-Coding Small Nucleolar RNA Host Genes (SNHGs) in Endocrine-Related Cancers.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Zhang H
Onco Targets Ther; 2020; 13():7699-7717. PubMed ID: 32848414
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy.
Feng P; Li Z; Li Y; Zhang Y; Miao X
Front Immunol; 2022; 13():799509. PubMed ID: 35799789
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA Small Nucleolar Host Gene: A Potential Therapeutic Target in Urological Cancers.
Yang Z; Li Q; Zheng X; Xie L
Front Oncol; 2021; 11():638721. PubMed ID: 33968736
[TBL] [Abstract][Full Text] [Related]
39. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
[TBL] [Abstract][Full Text] [Related]
40. Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma.
Zhen N; Zhu J; Mao S; Zhang Q; Gu S; Ma J; Zhang Y; Yin M; Li H; Huang N; Wu H; Sun F; Ying B; Zhou L; Pan Q
Cell Mol Gastroenterol Hepatol; 2023; 16(5):735-755. PubMed ID: 37478905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
